This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and ...

Shares of Puma Biotechnology PBYI have tanked 9.6% in the past month, reflecting the growing investor concern regarding the ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire ...

This biotech specializes in precision therapies for rare genetic diseases, with a pipeline targeting oncology and hematology indications.

Even on a budget, you can get quality stocks.

Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...

The company's stock value has tanked before - it was once worth $1 billion.